Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness

International drug regulators use conditional drug approval mechanisms to facilitate faster patient access to drugs based on a lower evidentiary standard typically required of drug approvals. Faster and earlier access is justified by limiting eligibility to drugs intended for serious and life-threat...

Descripción completa

Detalles Bibliográficos
Autores principales: McPhail, Melanie, Weiss, Emma, Bubela, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853442/
https://www.ncbi.nlm.nih.gov/pubmed/35186979
http://dx.doi.org/10.3389/fmed.2021.818647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853442/
https://www.ncbi.nlm.nih.gov/pubmed/35186979
http://dx.doi.org/10.3389/fmed.2021.818647

Ejemplares similares